Rating History for Bellerophon Therapeutics (BLPH) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/5/2023 | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
7.06 (0.01) |
-99.86% | Details |
 |
|||||||
|
|||||||
|
|||||||
